Disrupted Prefrontal Regulation of Social Rejection in Irritable Bowel Syndrome
Nana Xiong1, Qingtian Mi2, Qiqing Sun3
1Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Introduction:
Psychosocial stress plays a critical role in symptom exacerbation in irritable bowel syndrome (IBS), yet neural mechanisms linking social rejection to visceral pain remain poorly understood. This study examined the behavioral and neural responses to social rejection in patients with IBS, focusing on prefrontal regulation.
Methods:
Using functional magnetic resonance imaging and a validated social exclusion paradigm, we compared the behavioral and neural responses of 35 patients with IBS (Rome IV criteria, without comorbid depression or anxiety disorders) and 36 matched healthy controls (HCs). Participants experienced phases of inclusion, exclusion, and re-inclusion while reporting emotional distress and abdominal pain severity.
Results:
Compared to HCs, patients with IBS reported a greater increase in abdominal pain during exclusion and showed a pattern suggesting prolonged emotional distress upon re-inclusion. At the neural level, patients with IBS exhibited reduced activation in the dorsomedial prefrontal cortex (dmPFC) during exclusion and in the left inferior frontal gyrus (LIFG) during re-inclusion. Functional connectivity analyses further revealed altered interactions within prefrontal regions (LIFG-dmPFC) and between prefrontal and limbic areas (dmPFC-amygdala) in IBS. Moreover, greater dmPFC-amygdala coupling was associated with heightened emotional distress during social exclusion and was related to greater abdominal pain at 1-year follow-up.
Conclusions:
These findings indicate altered engagement and coordination of prefrontal regulatory networks during social rejection in IBS, offering insights into neural mechanisms linking psychosocial stress to pain chronicity in IBS.
More Related Videos
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...